<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03531489</url>
  </required_header>
  <id_info>
    <org_study_id>Penn 826372</org_study_id>
    <nct_id>NCT03531489</nct_id>
  </id_info>
  <brief_title>Study of Ambulatory Respiratory Assist Device in Chronic Obstructive Pulmonary Disease Patients</brief_title>
  <official_title>Pilot, Single Center Study of Ambulatory Respiratory Assist Device in Chronic Obstructive Pulmonary Disease Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Right-Air</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Right-Air</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a two-part small scale, open-label, pilot study to evaluate feasibility and
      proof-of-concept for a respiratory assist medical device. The study population will consist
      of severe Chronic Obstructive Pulmonary Disease (COPD) subjects.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 26, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess distance travelled during 6-minute walk tests performed with and without device.</measure>
    <time_frame>6 months</time_frame>
    <description>Distances travelled during two six minute walk tests will be measured. Investigator will compare distance travelled with use of the device to the distance travelled without the use of the device.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess for patient improvement in shortness of breath scores</measure>
    <time_frame>6 months</time_frame>
    <description>This will be be measured via survey tool Borg Scale of Dyspnea (0 - no dyspnea, through 10 - maximal dyspnea). Patient scores will be measured during exercise testing with and without the device. Improvement will be considered a lower score on the Borg Scale.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>COPD</condition>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Part 1: Feasibility</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will perform 6-minute walk test with AIR-AD to allow for observation and real-time feedback.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part 2: Crossover</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Crossover design where investigator will compare wearing of AIR-AD during exercise to compare distance walked with and without it.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AIR-AD</intervention_name>
    <description>Non-significant risk medical device as decided by institutional review board</description>
    <arm_group_label>Part 1: Feasibility</arm_group_label>
    <arm_group_label>Part 2: Crossover</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Moderate to severe COPD (by ATS criteria)

          1. FEV1/FVC &lt;0.70

          2. FEV1 &lt; 60% Predicted

        Exclusion Criteria:

          1. Physical limitation that prevents walking for 6 minutes (e.g. lower extremity
             amputation, arthritis limiting function, significant angina, etc…)

          2. Lung pathology not explained by COPD, which may limit functional capacity (e.g.
             pulmonary fibrosis, malignancy, history of lung reduction surgery, etc…)

          3. Pregnancy

          4. Age &lt;18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Hansen-Flaschen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Escobar</last_name>
    <phone>215-349-5023</phone>
    <email>escobarm@pennmedicine.upenn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Perry Dubin, MD/MPH</last_name>
    <phone>6105172053</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>John Hansen-Flaschen</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Escobar</last_name>
      <phone>215-349-5023</phone>
      <email>escobarm@pennmedicine.upenn.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2018</study_first_submitted>
  <study_first_submitted_qc>May 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2018</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

